梭狀桿菌檢驗的全球市場:市場規模(各市場區隔)，佔有率，法規，償付，預測(～2036年)

本報告提供全球梭狀桿菌檢驗市場相關調查分析，提供各地區市場規模，主要趨勢，與創新的產品技術，競爭情形等資訊。

市場模型的主要組成如下：

市場上的艱難梭菌檢測和不斷變化的競爭格局

• 主要產業趨勢分析
• 艱難梭菌檢測市場各細分市場的年收入及市場預測（2015 年至 2036 年）
• 有關單位數量、平均銷售價格和市場價值的市場層面數據

全球、區域和國家層面的市場洞察

• 按地區和全球趨勢細分的定性市場訊息，並提供每個國家/地區的市場洞察
• 艱難梭菌檢測市場的 SWOT 分析
• 艱難梭菌檢測市場競爭動態分析及趨勢

透過獲得真正的整體視角（包括醫療保健系統概述）來了解您的市場。此外，市場進入部分提供有關報銷政策和監管環境的信息，從而可以更深入地了解市場動態。

• 各國醫療保健體系概述
• 各國的報銷政策
• 各國醫療科技監理狀況

對象企業

• bioMerieux SA
• Meridian Bioscience Inc
• TECHLAB Inc
• Thermo Fisher Scientific Inc
• LG Life Science LTD
• Leica Microsystems Inc + Luminex Corp
• DiaSorin Molecular LLC + Luminex Corp
• Microbiologics Inc
• American Type Culture Collection
• 其他

Clostridium Difficile Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 is built to visualise quantitative and qualitative market trends within In Vitro Diagnostics therapeutic area.

Clostridium difficile Tests are carried out to diagnose the bacterium, commonly known as C. diff, that is a major cause of serious diarrheal infections, and may also cause colon cancer. Clostridium difficile Infection (CDI) is contagious and causes symptoms such as prolonged and frequent diarrhoea or watery stools, as well as pain or tenderness in the stomach, loss of appetite, fever and nausea.

People who are susceptible to CDI include the geriatric population, people with prolonged exposure to antibiotics, individuals recovering from recent hospitalization, people with weakened immunity, or those who have been infected with C. difficile in the past.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with installed base. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insights offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Clostridium difficile Tests and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Clostridium difficile Tests market revenue by segment and market outlooks from 2015-2036.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Clostridium Difficile Tests market.
• Competitive dynamics insights and trends provided for Clostridium Difficile Tests market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: bioMerieux SA, Meridian Bioscience Inc, TECHLAB Inc, Thermo Fisher Scientific Inc, LG Life Science LTD, Leica Microsystems Inc + Luminex Corp, DiaSorin Molecular LLC + Luminex Corp, Microbiologics Inc, American Type Culture Collection, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Clostridium Difficile Tests market place to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Clostridium Difficile Tests market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Clostridium Difficile Tests market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Track device sales in the global and country-specific Clostridium Difficile Tests market from 2015-2036.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Table of Contents

Not Applicable